Subscribe & Follow
Advertise your job vacancies
Trending
Show more
Vial-filling line boosts capacity
Rising capital costs means more and more pharmaceutical companies are outsourcing their manufacturing, which is why a decision by a US-based company to boost their manufacturing capability makes sense.
HollisterStier Laboratories LLC, a Spokane, WA contract manufacturer and aseptic processor/filler of commercial and clinical-trial sterile injectables, has a reputation for customer service and detailed project management. Its contract-manufacturing services focus on aseptic processing of lyophilized and liquid products, and it has experience commercializing vaccines, biological proteins, microspheres (a sphere sized from 0.5 to 100 mcm, made of any material), liposomes (artificial microscopic vesicles used to convey vaccines, drugs, enzymes or other substances to target cells or organs), suspensions and diluents.
The clinical-trial and commercial sterile injectables market is expected to increase 21 percent in the U.S., with more than 300 new, sterile product approvals expected by 2012. Approximately 25 percent of those are lyophilized drug products. Designed for multi-product operation, the Spokane facility manufactures products regulated as biologics, drugs and devices that range from Phase I clinical trial material to commercially available products.
Read the full article here.
